As of 2025-05-16, the Fair Value of Exagen Inc (XGN) is -4.33 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 5.74 USD, the upside of Exagen Inc is -175.46%.
With the market price of 5.74 USD and our fair value calculation, Exagen Inc (XGN) is not a good investment. Investing in XGN stocks now will result in a potential loss of 175.46%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -16.69 | -26.85 | -47.39 | -23.69 | -15.12 | -25.95 |
| YoY growth | -38.62% | -60.87% | -76.50% | 50.01% | 36.19% | -17.96% |
| Market Cap (mil) | 102.75 |
| P/E | |
| Forward P/E |
| EPS | -0.87 |
| Avg earnings growth rate | -17.96% |
| TTM earnings | -15.51 |